vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）とRevolve Group, Inc.（RVLV）の財務データ比較。上の社名をクリックして会社を切り替えられます
Revolve Group, Inc.の直近四半期売上が大きい（$324.4M vs $205.4M、COLLEGIUM PHARMACEUTICAL, INCの約1.6倍）。COLLEGIUM PHARMACEUTICAL, INCの純利益率が高く（8.3% vs 5.7%、差は2.5%）。COLLEGIUM PHARMACEUTICAL, INCの前年同期比売上増加率が高い（12.9% vs 10.4%）。COLLEGIUM PHARMACEUTICAL, INCの直近四半期フリーキャッシュフローが多い（$122.4M vs $-13.3M）。過去8四半期でCOLLEGIUM PHARMACEUTICAL, INCの売上複合成長率が高い（19.1% vs 9.5%）
コレギウムファーマシューティカルは、乱用抑止機能を持つ革新的な疼痛管理治療薬の開発・販売を専門とする米国の製薬企業です。主に米国市場で慢性疼痛患者向け徐放性鎮痛剤を提供し、一般医療・専門医療現場の医療従事者向けに製品を展開しています。
Revolve Theatre Companyはテムズ河畔ヘンリーを拠点とする劇団で、政治的なテーマの作品やシェイクスピア劇を専門に制作・上演しており、オリバー・デンチ、ジョー・モリス、トム・スミスの3人が所有しています。
COLL vs RVLV — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $205.4M | $324.4M |
| 純利益 | $17.0M | $18.6M |
| 粗利率 | 62.5% | 53.3% |
| 営業利益率 | 29.6% | 6.3% |
| 純利益率 | 8.3% | 5.7% |
| 売上前年比 | 12.9% | 10.4% |
| 純利益前年比 | 35.3% | 50.4% |
| EPS（希薄化後） | $0.48 | $0.27 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $205.4M | $324.4M | ||
| Q3 25 | $209.4M | $295.6M | ||
| Q2 25 | $188.0M | $309.0M | ||
| Q1 25 | $177.8M | $296.7M | ||
| Q4 24 | $181.9M | $293.7M | ||
| Q3 24 | $159.3M | $283.1M | ||
| Q2 24 | $145.3M | $282.5M | ||
| Q1 24 | $144.9M | $270.6M |
| Q4 25 | $17.0M | $18.6M | ||
| Q3 25 | $31.5M | $21.2M | ||
| Q2 25 | $12.0M | $10.2M | ||
| Q1 25 | $2.4M | $11.8M | ||
| Q4 24 | $12.5M | $12.3M | ||
| Q3 24 | $9.3M | $11.0M | ||
| Q2 24 | $19.6M | $15.4M | ||
| Q1 24 | $27.7M | $10.9M |
| Q4 25 | 62.5% | 53.3% | ||
| Q3 25 | 61.7% | 54.6% | ||
| Q2 25 | 57.7% | 54.1% | ||
| Q1 25 | 54.8% | 52.0% | ||
| Q4 24 | 54.0% | 52.5% | ||
| Q3 24 | 60.8% | 51.2% | ||
| Q2 24 | 62.5% | 54.0% | ||
| Q1 24 | 63.1% | 52.3% |
| Q4 25 | 29.6% | 6.3% | ||
| Q3 25 | 29.7% | 7.1% | ||
| Q2 25 | 18.7% | 5.8% | ||
| Q1 25 | 12.2% | 5.0% | ||
| Q4 24 | 20.9% | 3.9% | ||
| Q3 24 | 21.9% | 5.0% | ||
| Q2 24 | 32.7% | 5.8% | ||
| Q1 24 | 34.1% | 3.4% |
| Q4 25 | 8.3% | 5.7% | ||
| Q3 25 | 15.0% | 7.2% | ||
| Q2 25 | 6.4% | 3.3% | ||
| Q1 25 | 1.4% | 4.0% | ||
| Q4 24 | 6.9% | 4.2% | ||
| Q3 24 | 5.9% | 3.9% | ||
| Q2 24 | 13.5% | 5.4% | ||
| Q1 24 | 19.1% | 4.0% |
| Q4 25 | $0.48 | $0.27 | ||
| Q3 25 | $0.84 | $0.29 | ||
| Q2 25 | $0.34 | $0.14 | ||
| Q1 25 | $0.07 | $0.16 | ||
| Q4 24 | $0.36 | $0.18 | ||
| Q3 24 | $0.27 | $0.15 | ||
| Q2 24 | $0.52 | $0.21 | ||
| Q1 24 | $0.71 | $0.15 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $386.7M | $292.3M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $301.7M | $512.5M |
| 総資産 | $1.7B | $765.0M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $386.7M | $292.3M | ||
| Q3 25 | $285.9M | $315.4M | ||
| Q2 25 | $222.2M | $310.7M | ||
| Q1 25 | $197.8M | $300.8M | ||
| Q4 24 | $162.8M | $256.6M | ||
| Q3 24 | $120.0M | $252.8M | ||
| Q2 24 | $271.6M | $244.7M | ||
| Q1 24 | $318.0M | $273.4M |
| Q4 25 | $301.7M | $512.5M | ||
| Q3 25 | $274.8M | $490.2M | ||
| Q2 25 | $232.2M | $468.6M | ||
| Q1 25 | $234.4M | $453.4M | ||
| Q4 24 | $228.8M | $437.8M | ||
| Q3 24 | $234.3M | $420.8M | ||
| Q2 24 | $216.6M | $405.8M | ||
| Q1 24 | $222.2M | $389.9M |
| Q4 25 | $1.7B | $765.0M | ||
| Q3 25 | $1.6B | $751.3M | ||
| Q2 25 | $1.6B | $722.9M | ||
| Q1 25 | $1.6B | $713.9M | ||
| Q4 24 | $1.7B | $665.5M | ||
| Q3 24 | $1.6B | $670.9M | ||
| Q2 24 | $1.1B | $657.8M | ||
| Q1 24 | $1.1B | $650.0M |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $123.0M | $-10.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $122.4M | $-13.3M |
| FCFマージンFCF / 売上 | 59.6% | -4.1% |
| 設備投資強度設備投資 / 売上 | 0.3% | 1.0% |
| キャッシュ転換率営業CF / 純利益 | 7.25× | -0.55× |
| 直近12ヶ月FCF直近4四半期 | $327.6M | $48.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $123.0M | $-10.2M | ||
| Q3 25 | $78.4M | $11.8M | ||
| Q2 25 | $72.4M | $12.6M | ||
| Q1 25 | $55.4M | $45.1M | ||
| Q4 24 | $84.6M | $3.9M | ||
| Q3 24 | $-9.0M | $9.1M | ||
| Q2 24 | $67.4M | $-24.7M | ||
| Q1 24 | $61.9M | $38.4M |
| Q4 25 | $122.4M | $-13.3M | ||
| Q3 25 | $78.3M | $7.5M | ||
| Q2 25 | $72.4M | $10.4M | ||
| Q1 25 | $54.6M | $43.4M | ||
| Q4 24 | $84.1M | $2.1M | ||
| Q3 24 | $-9.2M | $8.0M | ||
| Q2 24 | $67.1M | $-25.7M | ||
| Q1 24 | $61.4M | $36.7M |
| Q4 25 | 59.6% | -4.1% | ||
| Q3 25 | 37.4% | 2.5% | ||
| Q2 25 | 38.5% | 3.4% | ||
| Q1 25 | 30.7% | 14.6% | ||
| Q4 24 | 46.2% | 0.7% | ||
| Q3 24 | -5.8% | 2.8% | ||
| Q2 24 | 46.2% | -9.1% | ||
| Q1 24 | 42.3% | 13.5% |
| Q4 25 | 0.3% | 1.0% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.3% | 0.6% | ||
| Q3 24 | 0.2% | 0.4% | ||
| Q2 24 | 0.2% | 0.4% | ||
| Q1 24 | 0.4% | 0.6% |
| Q4 25 | 7.25× | -0.55× | ||
| Q3 25 | 2.49× | 0.56× | ||
| Q2 25 | 6.05× | 1.24× | ||
| Q1 25 | 22.92× | 3.82× | ||
| Q4 24 | 6.75× | 0.32× | ||
| Q3 24 | -0.96× | 0.83× | ||
| Q2 24 | 3.44× | -1.60× | ||
| Q1 24 | 2.23× | 3.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
COLL
セグメントデータなし
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
